Catharina Svanborg
Voorzitter bij HAMLET PHARMA AB (PUBL)
Profiel
Catharina Svanborg is the founder of Hamlet BioPharma AB, which was founded in 1999.
She is also the founder of Linnane Pharma AB, founded in 2013, and SelectImmune Pharma AB, founded in 2017.
Currently, Dr. Svanborg holds the position of Director at the Royal Swedish Academy of Engineering Sciences since 1997 and the title of Professor-Clinical Immunology at the University of Lund since 1989.
Actieve functies van Catharina Svanborg
Bedrijven | Functie | Begin |
---|---|---|
HAMLET PHARMA AB (PUBL) | Voorzitter | 29-03-1999 |
SELECTIMMUNE PHARMA AB (PUBL) | Voorzitter | 10-02-2017 |
University of Lund | Corporate Officer/Principal | 01-01-1989 |
Linnane Pharma AB
Linnane Pharma AB BiotechnologyHealth Technology Linnane Pharma AB is a Swedish company that develops novel drugs to address major unmet medical needs in large patient groups. The company is based in Lund, Sweden. The company's goal is to alleviate cancer suffering and offer new treatments for bacterial infections, thereby reducing the need for toxic chemotherapies and the threat of antibiotic resistance. Linnane Pharma's projects include cancer therapy, immunotherapy for infections, and novel therapeutic concepts addressing important illness or health issues. The company was founded in 2013 by Catharina Svanborg, who is the chairman of the board and a professor of clinical immunology at Lund University. The CEO is Per Anders Jakob Testad. | Oprichter | 19-11-2013 |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Directeur/Bestuurslid | 01-01-1997 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HAMLET PHARMA AB (PUBL) | Health Technology |
SELECTIMMUNE PHARMA AB (PUBL) | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
Linnane Pharma AB
Linnane Pharma AB BiotechnologyHealth Technology Linnane Pharma AB is a Swedish company that develops novel drugs to address major unmet medical needs in large patient groups. The company is based in Lund, Sweden. The company's goal is to alleviate cancer suffering and offer new treatments for bacterial infections, thereby reducing the need for toxic chemotherapies and the threat of antibiotic resistance. Linnane Pharma's projects include cancer therapy, immunotherapy for infections, and novel therapeutic concepts addressing important illness or health issues. The company was founded in 2013 by Catharina Svanborg, who is the chairman of the board and a professor of clinical immunology at Lund University. The CEO is Per Anders Jakob Testad. | Health Technology |